Lloyd M Sems's most recent trade in Cyclacel Pharmaceuticals Inc was a trade of 31,645 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 14, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Cyclacel Pharmaceuticals Inc | Lloyd M. Sems | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 31,645 | 31,645 | - | - | Stock Option (right to buy) | |
Cyclacel Pharmaceuticals Inc | Lloyd M. Sems | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 15,822 | 18,196 (0%) | 0% | 0 | Common Stock | |
Cyclacel Pharmaceuticals Inc | Lloyd M. Sems | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 4,748 | 4,748 | - | - | Stock Option (right to buy) | |
Cyclacel Pharmaceuticals Inc | Lloyd M. Sems | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 2,374 | 2,374 (0%) | 0% | 0 | Common Stock | |
Cyclacel Pharmaceuticals Inc | Lloyd M. Sems | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2020 | 5,200 | 5,200 | - | - | Stock Option (right to buy) |